Caidya, a leading global mid-sized CRO, has announced the closing of a strategic growth investment of $165 million from funds managed by Rubicon Founders, a U.S.-based healthcare investment firm focused on building and growing transformational companies. With full-service capabilities and a strategic footprint in 23 countries and regions, Caidya is a global, mid-sized clinical research organization (CRO) dedicated to partnering with biopharma sponsors to ensure that every potential therapy has the best opportunity to reach patients in need.
Read the full article: Caidya Announces $165M Strategic Growth Investment from Rubicon Founders //
Source: https://www.businesswire.com/news/home/20250112736715/en/Caidya-Announces-165-Million-Strategic-Growth-Investment-From-Rubicon-Founders